Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
Saletu
B
B
Department of Psychiatry, University of Vienna, Austria.
Anderer
P
P
Semlitsch
H V
HV
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology*; D001921:Brain / Q000503:physiopathology*; D001931:Brain Mapping; D015161:Dementia, Multi-Infarct / Q000188:drug therapy / Q000503:physiopathology*; D004311:Double-Blind Method; D004569:Electroencephalography; D005072:Evoked Potentials, Auditory; D005260:Female; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D009530:Nicergoline / Q000008:administration & dosage*
D000317:Adrenergic alpha-Antagonists; D009530:Nicergoline